Houston, TX, United States of America

Elizabeth Shpall

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: The University of Texas System. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth Shpall. Retrieved from https://idiyas.com/inventor/elizabeth-shpall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Elizabeth Shpall: Innovator in Genome Editing

Introduction

Elizabeth Shpall is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of genome editing, particularly in enhancing the functionality and resistance of immune cells. Her innovative work is paving the way for advancements in medical treatments and therapies.

Latest Patents

Elizabeth Shpall holds a patent titled "Multiplex Genome Editing of Immune Cells to Enhance Functionality and Resistance to Suppressive Environment." This patent represents her commitment to improving immune cell performance, which is crucial for developing effective therapies against various diseases.

Career Highlights

Elizabeth is affiliated with The University of Texas System, where she continues her research and development in the field of genome editing. Her work is recognized for its potential impact on healthcare and biotechnology.

Collaborations

Elizabeth has collaborated with notable colleagues, including Rafet Basar and Katy Rezvani. These partnerships enhance her research efforts and contribute to the advancement of innovative solutions in the field.

Conclusion

Elizabeth Shpall is a trailblazer in genome editing, with her patent and collaborative efforts showcasing her dedication to improving immune cell functionality. Her work is essential for the future of medical innovation and treatment strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…